Jasmine Miller-Kleinhenz

TL;DR: These findings underscore the role of ecologic measures of structural racism on cancer outcomes, and place-based measures are important contributors to health outcomes, an important unexplored area that offers potential interventions to address disparities.

TL;DR: This study developed an ultra-small magnetic iron oxide nanoparticle (IONP) drug carrier conjugated with peptides that are dually targeted to Wnt/LRP5/6 and urokinase plasminogen activator receptor (uPAR) to effectively treat resistant tumors.

TL;DR: The current status of nanotherapeutic options for TNBC patients, identification of promising molecular targets, challenges associated with the development of targeted Nanotherapeutics, the research done by the group as well as by others, and future perspectives on the nanomedicine field and ways to translate current preclinical studies into the clinic are outlined.

TL;DR: HI showed remarkable tumor ablation efficiency, with magnetic targeting after 3 mg kg−1 intravenous administration (equivalent dose of free HCPT), and the tumors almost disappeared after treatment, suggesting that HIH is a promising theranostic nanocomplex with great translational potency.

TL;DR: A strong, positive association between BMI and CLS-B in non-tumor tissue similar to previous findings is shown and was not associated with worse OS or PFS.